Virobay

About:

Virobay develops small molecule, antiviral drug treatments for autoimmune diseases, neuropathic pain, liver diseases, and cancer.

Website: http://www.virobayinc.com

Top Investors: AbbVie, Perceptive Advisors, Sutter Hill Ventures, Alta Partners, TPG Growth

Description:

Virobay, Inc. operates as an anti-viral drug discovery and development company. It engages in developing, investigating, and creating treatments for hepatitis C, such as protease and polymerase inhibitors. The company was founded in 2006 and is headquartered in Menlo Park, California.